Thalassemia

ADAMS™ A1c HA-8180T

Thalassemia mode

Thalassemia is a disorder of the red blood cells where, due to a genetic defect, the haemoglobin cannot be created in sufficient amounts respectively is increased destructed.

This device makes it possible to detect and report normal and abnormal haemoglobin variants and is particularly suitable for testing for β-thalassemia.

The ADAMS™ A1c HA-8180 T uses HPLC measurement technology to analyse HbA1c (stabile HbA1c, S-A1c), HbA2, HbF with clear separation of the HbS, HbC, HbD, HbE, HbH, Hb Barts haemoglobins and detect further haemoglobin variants.

FAST – fast analysis (first report ≤ 5.4 minutes, from 2nd report only 3.5 minutes/test)
SIMPLE – only 3 eluents + haemolysis buffer (pre-filter is integrated into the column)
EXCELLENT PRECISION - HbA1c and HbA2 have a variation coefficient of <1%
MEQNET LINK SOFTWARE with chromatogram library

Further specifications

  • No column-bound reagents – the reagents can be changed at any time independently from the batch allocation.
  • All common test tubes can be used in a mixed rack
  • Fully automated operation
  • Cap piercing – pipetted from a closed primary test tube
  • Results reported in IFCC (mmol/mol) and NGSP (%) units
  • Continual analysis of up to 100 samples possible (load capacity)
  • Less maintenance required – no change of the pre-filter in the column